Pharmatech Associates Conference in Shanghai Lends Insight to Chinese Firms Looking to Meet New SFDA Regulatory Guidelines

HAYWARD, Calif.--(BUSINESS WIRE)--Pharmatech Associates, consultants to the pharmaceutical, biotech, medical device manufacturing and other regulated life sciences industries is hosting a pair of two-day conferences next week in Shanghai for companies working in biotech, biomedical, bio pharma, and other regulated areas of the biological sciences. The conferences (Sept. 14-15; Sept 17-18) will focus on new regulatory guidelines issued by the People’s Republic of China’s State Food and Drug Administration (SFDA) and how corporations can comply with such regulations in terms of Root Cause Analysis, CAPA, and Aseptic Engineering Design and Practices. During the conference, attendees will learn about compliance not just with SFDA guidelines, but also FDA requirements in the United States and the European Union.